[ Price : $8.95]
FDA is told by state representatives that the defining differences between compounding and manufacturing remain the major problem ...[ Price : $8.95]
Performance Plus Marketing recalls Libigrow, Libigrow XXXtreme, Blue Diamond, Blue Diamond Platinum, Mojo Nights, Mojo Nights Supr...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance, Certification Process for Designated Medical Gases.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Axiobionics, Basic Organics, Leisure Products, and Prime Herbs Corp.[ Price : $8.95]
FDAs Detroit District Office warns Axiobionics about Quality System and other violations in its manufacturing of electrical stimul...[ Price : $8.95]
FDA warns the Salem, Oregon, Hospital IRB about violations of the law and regulations that protect human research subjects.[ Price : $8.95]
FDA approves a Mylan Pharmaceuticals ANDA for a generic version of Mutual Pharmaceutical Co.s antimalarial Qualaquin.[ Price : $8.95]
FDA approves a Phase 2a IND trial of lisinopril for treating multiple sclerosis using telemonitoring instead of most patient trial...